neuromyelitis optica spectrum disorder
E1423953
UNEXPLORED
Neuromyelitis optica spectrum disorder is a rare autoimmune disease in which the immune system attacks the optic nerves and spinal cord, leading to episodes of vision loss and paralysis.
All labels observed (1)
| Label | Occurrences |
|---|---|
| neuromyelitis optica spectrum disorder canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T20301452 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: neuromyelitis optica spectrum disorder Context triple: [Alexion Pharmaceuticals, developsTreatmentFor, neuromyelitis optica spectrum disorder]
-
A.
ADEM
ADEM is the state agency responsible for administering and enforcing environmental laws and regulations in Alabama.
-
B.
relapsing-remitting multiple sclerosis
Relapsing-remitting multiple sclerosis is the most common form of multiple sclerosis, characterized by clearly defined attacks of neurological symptoms followed by periods of partial or complete recovery.
-
C.
Guillain–Barré syndrome
Guillain–Barré syndrome is an acute autoimmune disorder in which the immune system attacks peripheral nerves, leading to rapidly progressive muscle weakness and potential paralysis, often triggered by infections such as Campylobacter.
-
D.
Neurology: Neuroimmunology & Neuroinflammation
Neurology: Neuroimmunology & Neuroinflammation is a peer-reviewed medical journal focusing on research at the intersection of the nervous and immune systems, including mechanisms and treatment of neuroinflammatory and neuroimmunologic diseases.
-
E.
progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy is a rare, often fatal demyelinating brain disease caused by reactivation of the JC virus in immunocompromised individuals, leading to rapidly progressive neurological decline.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: neuromyelitis optica spectrum disorder Target entity description: Neuromyelitis optica spectrum disorder is a rare autoimmune disease in which the immune system attacks the optic nerves and spinal cord, leading to episodes of vision loss and paralysis.
-
A.
ADEM
ADEM is the state agency responsible for administering and enforcing environmental laws and regulations in Alabama.
-
B.
relapsing-remitting multiple sclerosis
Relapsing-remitting multiple sclerosis is the most common form of multiple sclerosis, characterized by clearly defined attacks of neurological symptoms followed by periods of partial or complete recovery.
-
C.
Guillain–Barré syndrome
Guillain–Barré syndrome is an acute autoimmune disorder in which the immune system attacks peripheral nerves, leading to rapidly progressive muscle weakness and potential paralysis, often triggered by infections such as Campylobacter.
-
D.
Neurology: Neuroimmunology & Neuroinflammation
Neurology: Neuroimmunology & Neuroinflammation is a peer-reviewed medical journal focusing on research at the intersection of the nervous and immune systems, including mechanisms and treatment of neuroinflammatory and neuroimmunologic diseases.
-
E.
progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy is a rare, often fatal demyelinating brain disease caused by reactivation of the JC virus in immunocompromised individuals, leading to rapidly progressive neurological decline.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.